Skip to main content

Table 1 The Main evaluated participants’ demographic, laboratory and imaging criteria

From: The role of shear wave elastography in differentiation between benign and malignant portal vein thrombosis in hepatocellular carcinoma

Participants’ criteria All participants n = 78 (100%) Malignant PVT n = 61 (78.2%) Benign PVT n = 17 (21.8%) Sig
Demographic criteria
 Age (ys) Median (IQR) 60 (12) 60 (12) 62 (16) 0.716
 Sex
  Male Count (%) 45 (57.7%) 34 (55.7%) 11 (64.7%) 0.508
  Female Count (%) 33 (42.3%) 27 (44.3%) 6 (35.3%)
Liver functions
 ALT (IU/L) Median (IQR) 41 (17) 41 (17) 40 (12) 0.611
 AST (IU/L) Median (IQR) 46 (16) 48 (14) 43 (13) 0.085
 Serum albumin (gm/dl) Median (IQR) 2.9 (0.6) 2.9 (0.7) 2.7 (0.5) 0.468
 Serum bilirubin (mg/dl) Median (IQR) 1.9 (0.5) 1.8 (0.6) 1.9 (0.6) 0.258
 INR Median (IQR) 1.8 (0.2) 1.8 (0.2) 1.9 (0.4) 0.201
 Child–Pugh grade
  A Count (%) 8 (10.3%) 7 (11.5%) 1 (5.9%) 0.128
  B Count (%) 52 (66.7%) 43 (70.5%) 9 (52.9%)
  C Count (%) 18 (23.1%) 11 (18%) 7 (41.2%)
Other laboratory parameters
 Hemoglobin (g/dl) Median (IQR) 11.7 (1.6) 11.7 (1.7) 11.6 (1.4) 0.904
 White blood cells (× 103/mm3) Median (IQR) 6.4 (3.7) 5.9 (3.2) 7.9 (4.6) 0.145
 Platelets (× 103/mm3) Median (IQR) 123 (35) 123 (33) 115 (59) 0.712
 Serum creatinine (mg/dl) Median (IQR) 1.0 (0.2) 1.1 (0.1) 1 (0.2) 0.236
Criteria related to HCC
 HCC focality
  Multifocal Count (%) 45 (57.7%) 39 (63.9%) 6 (35.3%) 0.035
  Unifocal Count (%) 33 (42.3%) 22 (36.1%) 11 (64.7%)
 HCC size (cm) Median (IQR) 5.4 (2.1) 5.6 (2.4) 4.5 (1.3) 0.000
 AFP (ngm/ml) Median (IQR) 215 (521) 323 (630) 21 (60) 0.000
Criteria related PVT
 PVD (mm) Median (IQR) 18 (5) 19 (5) 14 (3) 0.000
 SWE (kps) Median (IQR) 20.8 (13.7) 22.7 (9.1) 8.2 (3.5) 0.000
  1. ALT Alanin aminotransferase, AST Aspartate aminotransferase, INR International normalized ratio, PVT Portal vein thrombosis, PVD Portal vein diameter, KPa Kilopascal, SWE Shear wave elastography